Ropes & Gray represented the underwriters in Biohaven Ltd.’s $264.5 million follow-on offering. Biohaven intends to use the proceeds from the offering to fund general corporate purposes. The offering was announced in a press release on April 18 and closed on April 22.
Biohaven is a biopharmaceutical company focused on the discovery, development and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience and oncology.
The team was led by capital markets partners Will Michener and Daniel Forman, IP transactions partner Melissa Rones, life sciences regulatory & compliance partner Kellie Combs, and tax partner David Saltzman.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
